[1. WORLD HEALTH ORGANISATION. GLOBAL STRATEGY ON DIET, PHYSICAL ACTIVITY AND HEALTH. http://www.who.int/dietphysicalactivity/childhood/en/ accessed on 27/09/2017.]Search in Google Scholar
[2. FARAG Y.M., GABALLA MR. Diabesity: an overview of a rising epidemic. Nephrol Dial Transplant. 2011; 26(1):28-35.10.1093/ndt/gfq57621045078]Search in Google Scholar
[3. ZIMMET P., ALBERTI K.G., KAUFMAN F., TAJIMA N., SILINK M., ARSLANIAN S. et al. IDF Consensus group. The metabolic syndrome in children and adolescents – an IDF consensus report. Pediatr Diabetes. 2007; 8(5):299-306.10.1111/j.1399-5448.2007.00271.x17850473]Open DOISearch in Google Scholar
[4. VAJRO P., LENTA S., SOCHA P., DHAWAN A., MCKIERNAN P., BAUMANN U. et al. Diagnosis of nonalcoholic fatty liver disease in children and adolescents: position paper of the ESPGHAN Hepatology Committee. J Pediatr Gastroenterol Nutr. 2012; 54(5):700-13.10.1097/MPG.0b013e318252a13f22395188]Open DOISearch in Google Scholar
[5. DI BONITO P, VALERIO G, GRUGNI G, LICENZIATI MR, MAFFEIS C, MANCO M et al. CARdiometabolic risk factors in overweight and obese children in ITALY (CARITALY) Study Group. Comparison of non-HDL-cholesterol versus triglyceridesto-HDL-cholesterol ratio in relation to cardiometabolic risk factors and preclinical organ damage in overweight/obese children: the CARITALY study. Nutr Metab Cardiovasc Dis. 2015; 25(5):489-94.10.1016/j.numecd.2015.01.01225813687]Search in Google Scholar
[6. VIRANI SS. Non-HDL Cholesterol as a metric of good quality of care: Opportunities and challenges. Coulter SA, ed. Texas Heart Institute Journal. 2011; 38(2):160-162.]Search in Google Scholar
[7. OLIVEIRA, A., OLIVEIRA, A., OLIVEIRA, N., OLIVEIRA, A., ALMEIDA, M., VENEZA L. et al. Is triglyceride to highdensity lipoprotein cholesterol ratio a surrogates for insulin resistance in youth? Health. 2013; 5, 481-485.10.4236/health.2013.53066]Open DOISearch in Google Scholar
[8. CENTER FOR DISEASE CONTROL AND PREVENTION https://www.cdc.gov/growthcharts/cdc_charts.htm, accessed on 27/09/2017.]Search in Google Scholar
[9. FERNÁNDEZ JR, REDDEN DT, PIETROBELLI A, ALLISON DB. Waist circumference percentiles in nationally representative samples of African-American, European-American, and Mexican-American children and adolescents. J Pediatr. 2004; 145(4):439-44.10.1016/j.jpeds.2004.06.04415480363]Search in Google Scholar
[10. FRISANCHO AR. New norms of upper limb fat and muscle areas for assessment of nutritional status. Am J Clin Nutr. 1981; 34(11):2540-5.697556410.1093/ajcn/34.11.25406975564]Search in Google Scholar
[11. WHO IRIS (INSTITUTIONAL REPOSITORY FOR INFORMATION SHARING) http://apps.who.int/iris/handle/10665/43376 accessed on 27/09/2017.]Search in Google Scholar
[12. SCHWIMMER JB, DUNN W, NORMAN GJ, PARDEE PE, MIDDLETON MS, KERKAR N. et al. SAFETY study: alanine aminotransferase cutoff values are set too high for reliable detection of pediatric chronic liver disease. Gastroenterology 2010; 138:1357–64.10.1053/j.gastro.2009.12.052284696820064512]Search in Google Scholar
[13. ATABEK ME, SELVER EKLIOGLU B, AKYÜREK N. Which metabolic syndrome criteria best predict non-alcoholic fatty liver disease in children? Eat Weight Disord. 2014; 19(4):495-501.10.1007/s40519-014-0129-024844310]Search in Google Scholar
[14. VOS MB, ABRAMS SH, BARLOW SE, CAPRIO S, DANIELS SR, KOHLI R. et al. NASPGHAN Clinical practice guideline for the diagnosis and treatment of nonalcoholic fatty liver disease in children: Recommendations from the Expert Committee on NAFLD (ECON) and the North American Society of Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN). J Pediatr Gastroenterol Nutr. 2017; 64(2):319-334.10.1097/MPG.0000000000001482541393328107283]Open DOISearch in Google Scholar
[15. WEISS R, OTVOS JD, SINNREICH R, MISEREZ AR, KARK JD. The triglyceride to high-density lipoprotein-cholesterol ratio in adolescence and subsequent weight gain predict nuclear magnetic resonance-measured lipoprotein subclasses in adulthood. J Pediatr. 2011; 158(1):44-50.10.1016/j.jpeds.2010.07.00220801459]Search in Google Scholar
[16. SULLIVAN JS, LE MT, PAN Z, RIVARD C, LOVE-OSBORNE K, ROBBINS K. et al. Oral fructose absorption in obese children with non-alcoholic fatty liver disease. Pediatric obesity. 2015; 10(3):188-195.10.1111/ijpo.238494898824961681]Search in Google Scholar
[17. SONG P, YU J, WANG M, CHANG X, WANG J, AN L. Prevalence and correlates of suspected nonalcoholic fatty liver disease in Chinese children. Int J Environ Res Public Health. 2017; 27; 14(5).10.3390/ijerph14050465545191628448433]Search in Google Scholar
[18. ANDERSON EL, HOWE LD, JONES HE, HIGGINS JP, LAWLOR DA, FRASER A. The Prevalence of non-alcoholic fatty liver disease in children and adolescents: A systematic review and meta-analysis. PLoS One. 2015; 29; 10(10):e0140908.10.1371/journal.pone.0140908462602326512983]Search in Google Scholar
[19. EXPERT PANEL ON INTEGRATED GUIDELINES FOR CARDIOVASCULAR HEALTH AND RISK REDUCTION IN CHILDREN AND ADOLESCENTS; National Heart, Lung, and Blood Institute. Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report. Pediatrics. 2011; 128 Suppl 5:S213-56.10.1542/peds.2009-2107C453658222084329]Search in Google Scholar
[20. LOOMBA R, ABRAHAM M, UNALP A, WILSON L, LAVINE J, DOO E. et al. Nonalcoholic steatohepatitis clinical research network. Association between diabetes, family history of diabetes, and risk of nonalcoholic steatohepatitis and fibrosis. Hepatology. 2012; 56(3):943-51.10.1002/hep.25772340728922505194]Open DOISearch in Google Scholar